However, due to reduced levels of MHC class I and CD86 on antigen-presenting cells in S47 TBM, we interrogated whether the frequency of tumor-specific CD8+ T cells were significantly different between S47 and P47 TBM. This evidence concerns the gene CD86 and neoplasm.